InvestorsHub Logo
Followers 191
Posts 16408
Boards Moderated 8
Alias Born 01/29/2018

Re: stervc post# 16567

Sunday, 08/30/2020 7:19:39 PM

Sunday, August 30, 2020 7:19:39 PM

Post# of 63377
That $1.20 per share "worst case" is not only unrealistic, it is completely absurd. This company failed. Its tech hasn't attracted interest in the 3 years since the FDA approved the phase 2 trial. See all that stuff in the iBox, the slides? They were used in the last pitch to companies/investors in the business of funding these sorts of trials and got nothing from it.

It is preposterous to think that those companies, the ones who know about these trials and this tech, somehow missed a multi-billion dollar company, but penny stock funders and traders figured it out.

Funny thing about OTC "projections" like this, they never ever come true, now, do they? In fact, they all wind up being pump and dumps. Each and every one.

So they did what stinky pink companies do, they upped their A/S to 2B, converted a little debt into 1.6B shares of stock, much of it at $0.001, then asked FINRA for a RS, which was denied. That happened over the course of only 3 months.

Now they're in bankruptcy, and all this rhetoric about trading stock for $15M of debt suddenly creating a multi-billion dollar company is just that, rhetoric. If the "plan" is confirmed, they'll have maybe a year's worth of pay for the 5-7 employees, and that's it. They'll still need funding for the phase 2 trial, which will take years, then they'll need even more funding. And that assumes they ever get started.

I swear I’ll never use the phrase “you can’t make this stuff up” ever again after being on the OTC. Apparently you can.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BRTX News